191 related articles for article (PubMed ID: 10992352)
21. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
22. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
23. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
24. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
25. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
26. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for prostate cancer.
Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
[TBL] [Abstract][Full Text] [Related]
29. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
30. Strategies for enhancing viral-based gene therapy using ionizing radiation.
Chmura SJ; Advani SJ; Kufe DW; Weichselbaum RR
Radiat Oncol Investig; 1999; 7(5):261-9. PubMed ID: 10580895
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer gene therapy: outcome of basic research and clinical trials.
Nasu Y; Djavan B; Marberger M; Kumon H
Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255
[TBL] [Abstract][Full Text] [Related]
32. [Gene therapy for prostate cancer].
Gotoh A; Shirakawa T; Wada Y; Hinata N; Matsubara S; Hara I; Fujisawa M; Okada H; Arakawa S; Kamidono S
Hinyokika Kiyo; 2002 Nov; 48(11):729-32. PubMed ID: 12512150
[TBL] [Abstract][Full Text] [Related]
33. [Prostate cancer gene therapy].
Nasu Y; Kumon H
Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
Bauerschmitz GJ; Barker SD; Hemminki A
Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
[TBL] [Abstract][Full Text] [Related]
36. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
[TBL] [Abstract][Full Text] [Related]
37. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
Lee YJ; Lee H; Borrelli MJ
Cancer Gene Ther; 2002 Mar; 9(3):267-74. PubMed ID: 11896443
[TBL] [Abstract][Full Text] [Related]
38. Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.
Vajda A; Marignol L; Foley R; Lynch TH; Lawler M; Hollywood D
Cancer Treat Rev; 2011 Dec; 37(8):643-54. PubMed ID: 21481534
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
40. Combining gene and immunotherapy for prostate cancer.
Young JG; Green NK; Mautner V; Searle PF; Young LS; James ND
Prostate Cancer Prostatic Dis; 2008; 11(2):187-93. PubMed ID: 17726452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
